Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Valentina Nardi, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Bennett JA, Pesci A, Morales-Oyarvide V, Da Silva A, Nardi V, Oliva E. Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104 Ovarian Endometrioid Carcinomas. Am J Surg Pathol. 2019 Feb; 43(2):235-243. PMID: 30256257.
    Citations:    Fields:    
  2. Chougule A, Taylor MS, Nardi V, Chebib I, Cote GM, Choy E, Nielsen GP, Deshpande V. Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation. Am J Surg Pathol. 2019 Feb; 43(2):220-228. PMID: 30379650.
    Citations:    Fields:    
  3. Boiocchi L, Hasserjian RP, Pozdnyakova O, Wong WJ, Lennerz JK, Le LP, Dias-Santagata D, Iafrate AJ, Hobbs GS, Nardi V. Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. Hum Pathol. 2018 Dec 27. PMID: 30594750.
    Citations:    Fields:    
  4. Bale TA, Jordan JT, Rapalino O, Ramamurthy N, Jessop N, DeWitt JC, Nardi V, Martinez-Lage Alvarez M, Frosch M, Batchelor TT, Louis DN, Iafrate AJ, Cahill DP, Lennerz JK. Financially Effective Test-Algorithm to Identify an Aggressive, EGFR-amplified Variant of IDH-Wildtype, Lower-Grade Diffuse Glioma. Neuro Oncol. 2018 Nov 28. PMID: 30496526.
    Citations:    Fields:    
  5. Troschel FM, Gottumukkala RV, DiCorpo D, Mario J, Ott HC, Wright CD, Muniappan A, Lanuti M, Yang K, Shepard JO, Nardi V, Michaelson JS, Hariri LP, Fintelmann FJ. Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study. Arch Pathol Lab Med. 2019 Mar; 143(3):319-325. PMID: 30457896.
    Citations:    Fields:    
  6. Bardia A, Hovnanian MD, Brachtel EF, Nardi V. Case 35-2018: A 68-Year-Old Woman with Back Pain and a Remote History of Breast Cancer. N Engl J Med. 2018 Nov 15; 379(20):1946-1953. PMID: 30428289.
    Citations:    Fields:    Translation:Humans
  7. Jeck WR, Lee J, Robinson H, Le LP, Iafrate AJ, Nardi V. A Nanopore Sequencing-Based Assay for Rapid Detection of Gene Fusions. J Mol Diagn. 2019 Jan; 21(1):58-69. PMID: 30273778.
    Citations:    Fields:    
  8. Maranella E, Mareri A, Nardi V, Di Natale C, Di Luca L, Conte E, Pannone V, Catalucci A, Di Fabio S. Severe neurologic and hepatic toxicity in a newborn prenatally exposed to methamphetamine. A case report. Brain Dev. 2019 Feb; 41(2):191-194. PMID: 30213441.
    Citations:    Fields:    
  9. Shiota H, Elya JE, Alekseyenko AA, Chou PM, Gorman SA, Barbash O, Becht K, Danga K, Kuroda MI, Nardi V, French CA. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism. Mol Cancer Res. 2018 Dec; 16(12):1826-1833. PMID: 30139738.
    Citations:    Fields:    
  10. Dagogo-Jack I, Azzolli CG, Fintelmann F, Mino-Kenudson M, Farago AF, Gainor JF, Jiang G, Piotrowska Z, Heist RS, Lennes IT, Temel JS, Mooradian MJ, Lin JJ, Digumarthy SR, Batten JM, Robinson H, Nose V, Rivera M, Nardi V, Dias-Santagata D, Le LP, Sequist LV, Pitman M, Shepard JO, Shaw AT, Iafrate AJ, Lennerz JK. Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer. JCO Precis Oncol. 2018; 2018. PMID: 30370396.
    Citations:    
  11. Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia NV, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018 05 22; 9(1):2024. PMID: 29789628.
    Citations:    Fields:    Translation:HumansAnimalsCells
  12. Siegele BJ, Nardi V. Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma. Am J Hematol. 2018 Jul; 93(7):971-977. PMID: 29696694.
    Citations:    Fields:    
  13. Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, Chen YA, Fathi AT, Graubert TA, Brunner AM, Wadleigh M, Stone RM, DeAngelo DJ, Nardi V, Hasserjian RP, Weinberg OK. High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML. Blood. 2018 Jun 21; 131(25):2816-2825. PMID: 29724895.
    Citations:    
  14. Asleh R, Prasad M, Briasoulis A, Nardi V, Adigun R, Edwards BS, Pereira NL, Daly RC, Lerman A, Kushwaha SS. Uric acid is an independent predictor of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant. 2018 Sep; 37(9):1083-1092. PMID: 29802086.
    Citations:    Fields:    
  15. Tse JY, Chan MP, Ferry JA, Deshpande V, Sohani AR, Nardi V, Schaffer A, Nazarian RM, Zukerberg LR. Syphilis of the Aerodigestive Tract. Am J Surg Pathol. 2018 04; 42(4):472-478. PMID: 29135519.
    Citations:    Fields:    
  16. Nizi E, Sferrazza A, Fabbrini D, Nardi V, Andreini M, Graziani R, Gennari N, Bresciani A, Paonessa G, Harper S. Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins. Bioorg Med Chem Lett. 2018 05 15; 28(9):1540-1544. PMID: 29615344.
    Citations:    Fields:    Translation:HumansCells
  17. Zomnir MG, Lipkin L, Pacula M, Meneses ED, MacLeay A, Duraisamy S, Nadhamuni N, Al Turki SH, Zheng Z, Rivera M, Nardi V, Dias-Santagata D, Iafrate AJ, Le LP, Lennerz JK. Artificial Intelligence Approach for Variant Reporting. JCO Clin Cancer Inform. 2018; 2. PMID: 30364844.
    Citations:    
  18. Michaels PD, Robinson H, Nardi V, Iafrate AJ, Le L, Lennerz JK. MET Amplification in Esophageal Squamous Carcinoma. Int J Surg Pathol. 2018 12; 26(8):731-732. PMID: 29552946.
    Citations:    Fields:    
  19. Hung YP, Dong F, Watkins JC, Nardi V, Bueno R, Dal Cin P, Godleski JJ, Crum CP, Chirieac LR. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma. JAMA Oncol. 2018 Feb 01; 4(2):235-238. PMID: 28910456.
    Citations: 6     Fields:    
  20. Church AJ, Calicchio ML, Nardi V, Skalova A, Pinto A, Dillon DA, Gomez-Fernandez CR, Manoj N, Haimes JD, Stahl JA, Dela Cruz FS, Tannenbaum-Dvir S, Glade-Bender JL, Kung AL, DuBois SG, Kozakewich HP, Janeway KA, Perez-Atayde AR, Harris MH. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. Mod Pathol. 2018 03; 31(3):463-473. PMID: 29099503.
    Citations: 1     Fields:    
  21. Bellieni CV, Nardi V, Buonocore G, Di Fabio S, Pinto I, Verrotti A. Electromagnetic fields in neonatal incubators: the reasons for an alert. J Matern Fetal Neonatal Med. 2019 Feb; 32(4):695-699. PMID: 28988507.
    Citations:    Fields:    
  22. Ryan RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP, Blacklow SC, Weinstock DM, Faryabi RB, Bernstein BE, Aster JC, Pear WS. A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Rep. 2017 Oct 17; 21(3):784-797. PMID: 29045844.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  23. Ritterhouse LL, Vivero M, Mino-Kenudson M, Sholl LM, Iafrate AJ, Nardi V, Dong F. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas. Mod Pathol. 2017 12; 30(12):1720-1727. PMID: 28776576.
    Citations: 2     Fields:    Translation:Humans
  24. Bennett JA, Nardi V, Rouzbahman M, Morales-Oyarvide V, Nielsen GP, Oliva E. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum. Mod Pathol. 2017 10; 30(10):1489-1503. PMID: 28664932.
    Citations: 3     Fields:    Translation:Humans
  25. Bellieni CV, Tei M, Cornacchione S, Di Lucia S, Nardi V, Verrotti A, Buonocore G. Pain perception in NICU: a pilot questionnaire. J Matern Fetal Neonatal Med. 2018 Jul; 31(14):1921-1923. PMID: 28514889.
    Citations:    Fields:    Translation:Humans
  26. Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, Kovach AE, Masih A, Nishino HT, Weiss LM, Meeker AK, Nardi V, Palisoc M, Shao L, Pittaluga S, Ferry JA, Harris NL, Sohani AR. Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation. Am J Surg Pathol. 2017 Mar; 41(3):299-312. PMID: 28195879.
    Citations: 4     Fields:    Translation:Humans
  27. Blute ML, Abramson JS, Cronin KC, Nardi V. Case 5-2017. A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass. N Engl J Med. 2017 02 16; 376(7):684-692. PMID: 28199810.
    Citations:    Fields:    Translation:Humans
  28. Goyal L, Zheng H, Yurgelun MB, Abrams TA, Allen JN, Cleary JM, Knowles M, Regan E, Reardon A, Khachatryan A, Jain RK, Nardi V, Borger DR, Duda DG, Zhu AX. A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Cancer. 2017 06 01; 123(11):1979-1988. PMID: 28192597.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  29. Weinberg OK, Sohani AR, Bhargava P, Nardi V. Diagnostic work-up of acute myeloid leukemia. Am J Hematol. 2017 Mar; 92(3):317-321. PMID: 28066929.
    Citations: 1     Fields:    Translation:Humans
  30. Comparetto C, Epifani C, Manca MC, Lachheb A, Bravi S, Cipriani F, Bellomo F, Olivieri S, Fiaschi C, Di Marco L, Nardi V, Spinelli G, Borruto F. Uptake of cervical cancer screening among the migrant population of Prato Province, Italy. Int J Gynaecol Obstet. 2017 Mar; 136(3):309-314. PMID: 28099681.
    Citations:    Fields:    Translation:HumansPHPublic Health
  31. Bennett JA, Oliva E, Nardi V, Lindeman N, Ferry JA, Louissaint A. Primary Endometrial Marginal Zone Lymphoma (MALT Lymphoma): A Unique Clinicopathologic Entity. Am J Surg Pathol. 2016 09; 40(9):1217-23. PMID: 27340748.
    Citations: 1     Fields:    Translation:Humans
  32. Bardia A, Iafrate JA, Sundaresan T, Younger J, Nardi V. Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital. Oncologist. 2016 09; 21(9):1035-40. PMID: 27551012; PMCID: PMC5016066.
    Citations: 5     Fields:    Translation:HumansCells
  33. Courville EL, Yohe S, Chou D, Nardi V, Lazaryan A, Thakral B, Nelson AC, Ferry JA, Sohani AR. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations. Mod Pathol. 2016 10; 29(10):1200-11. PMID: 27443517.
    Citations: 2     Fields:    Translation:Humans
  34. Nardi V, Hasserjian RP. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Surg Pathol Clin. 2016 Mar; 9(1):143-63. PMID: 26940274.
    Citations:    Fields:    Translation:HumansCells
  35. Mattiucci S, Cipriani P, Paoletti M, Nardi V, Santoro M, Bellisario B, Nascetti G. Temporal stability of parasite distribution and genetic variability values of Contracaecum osculatum sp. D and C. osculatum sp. E (Nematoda: Anisakidae) from fish of the Ross Sea (Antarctica). Int J Parasitol Parasites Wildl. 2015 Dec; 4(3):356-67. PMID: 26767164; PMCID: PMC4683570.
    Citations:    
  36. Platt MY, Fathi AT, Borger DR, Brunner AM, Hasserjian RP, Balaj L, Lum A, Yip S, Dias-Santagata D, Zheng Z, Le LP, Graubert TA, Iafrate AJ, Nardi V. Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. J Mol Diagn. 2015 Nov; 17(6):661-8. PMID: 26331834; PMCID: PMC4630164.
    Citations: 3     Fields:    Translation:Humans
  37. Goyal L, Govindan A, Sheth RA, Nardi V, Blaszkowsky LS, Faris JE, Clark JW, Ryan DP, Kwak EL, Allen JN, Murphy JE, Saha SK, Hong TS, Wo JY, Ferrone CR, Tanabe KK, Chong DQ, Deshpande V, Borger DR, Iafrate AJ, Bardeesy N, Zheng H, Zhu AX. Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma. Oncologist. 2015 Sep; 20(9):1019-27. PMID: 26245674; PMCID: PMC4571807.
    Citations: 12     Fields:    Translation:Humans
  38. Ryan RJ, Drier Y, Whitton H, Cotton MJ, Kaur J, Issner R, Gillespie S, Epstein CB, Nardi V, Sohani AR, Hochberg EP, Bernstein BE. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. Cancer Discov. 2015 Oct; 5(10):1058-71. PMID: 26229090; PMCID: PMC4592453.
    Citations: 23     Fields:    Translation:HumansCells
  39. Nardi V, Pulluqi O, Abramson JS, Dal Cin P, Hasserjian RP. Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information. Am J Hematol. 2015 Jun; 90(6):529-33. PMID: 25776302.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  40. Gandhi RT, Alkasab TK, Nardi V, Branda JA. Case records of the Massachusetts General Hospital. Case 40-2014. A 57-year-old man with inguinal pain, lymphadenopathy, and HIV infection. N Engl J Med. 2014 Dec 25; 371(26):2511-20. PMID: 25539108.
    Citations:    Fields:    Translation:HumansCells
  41. Cleven AH, Nardi V, Ok CY, Goswami M, Dal Cin P, Zheng Z, Iafrate AJ, Abdul Hamid MA, Wang SA, Hasserjian RP. High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome. Mod Pathol. 2015 Apr; 28(4):552-63. PMID: 25412846.
    Citations: 5     Fields:    Translation:Humans
  42. O'Donnell E, Mahindra A, Yee AJ, Nardi V, Birrer N, Horick N, Borger D, Finkelstein D, Iafrate JA, Raje N. Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma. EBioMedicine. 2015 Jan; 2(1):71-3. PMID: 26137536; PMCID: PMC4485483.
    Citations: 1     Fields:    Translation:HumansCells
  43. Pukkila-Worley R, Nardi V, Branda JA. Case records of the Massachusetts General Hospital. Case 28-2014. A 39-year-old man with a rash, headache, fever, nausea, and photophobia. N Engl J Med. 2014 Sep 11; 371(11):1051-60. PMID: 25207769.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  44. Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 2014 May; 4(5):554-63. PMID: 24631838; PMCID: PMC4012430.
    Citations: 86     Fields:    Translation:HumansAnimalsCells
  45. Carter JB, Barnes JA, Niell BL, Nardi V. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy. N Engl J Med. 2013 Aug 08; 369(6):559-69. PMID: 23924007.
    Citations:    Fields:    Translation:Humans
  46. Santoro M, Mattiucci S, Work T, Cimmaruta R, Nardi V, Cipriani P, Bellisario B, Nascetti G. Parasitic infection by larval helminths in Antarctic fishes: pathological changes and impact on the host body condition index. Dis Aquat Organ. 2013 Jul 22; 105(2):139-48. PMID: 23872857.
    Citations: 4     Fields:    Translation:Animals
  47. Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, Dias-Santagata D, Cusack JC. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol. 2013 Apr; 20(4):1365-73. PMID: 23208132.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  48. Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler D, Li Y, Wirth LJ, Dias-Santagata D. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Clin Cancer Res. 2013 Jan 15; 19(2):480-90. PMID: 23186780.
    Citations: 23     Fields:    Translation:Humans
  49. Cai A, Keskin DB, DeLuca DS, Alonso A, Zhang W, Zhang GL, Hammond NN, Nardi V, Stone RM, Neuberg D, Sidney J, Brusic V, Wu CJ. Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients. Clin Cancer Res. 2012 Oct 15; 18(20):5761-72. PMID: 22912393; PMCID: PMC3759991.
    Citations: 13     Fields:    Translation:HumansCells
  50. Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. J Clin Oncol. 2012 Jul 01; 30(19):2340-7. PMID: 22585703; PMCID: PMC4979234.
    Citations: 18     Fields:    Translation:Humans
  51. Colpo A, Wilson FH, Nardi V, Hochberg E. Administration of vincristine in a patient with Machado-Joseph disease. Oncology. 2012; 82(3):165-7. PMID: 22433430; PMCID: PMC3701890.
    Citations: 1     Fields:    Translation:Humans
  52. Nardi V, Song Y, Santamaria-Barria JA, Cosper AK, Lam Q, Faber AC, Boland GM, Yeap BY, Bergethon K, Scialabba VL, Tsao H, Settleman J, Ryan DP, Borger DR, Bhan AK, Hoang MP, Iafrate AJ, Cusack JC, Engelman JA, Dias-Santagata D. Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res. 2012 Mar 01; 18(5):1227-36. PMID: 22261808; PMCID: PMC3912509.
    Citations: 29     Fields:    Translation:HumansCells
  53. Wirth LJ, Nardi V, Juric D, Cosper AK, Bergethon K, Scialabba V, Borger DR, Iafrate AJ, Ellisen LW, Deschler D, Zhao D, Sadow PM, Dias-Santagata D. Detection of novel genetic aberrations in salivary duct carcinoma (SDC) by SNaPshot analysis. J Clin Oncol. 2011 May 20; 29(15_suppl):5579. PMID: 28022120.
    Citations:    
  54. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009 Jul 09; 460(7252):259-63. PMID: 19516257; PMCID: PMC2831539.
    Citations: 280     Fields:    Translation:AnimalsCells
  55. Le Y, Xu L, Lu J, Fang J, Nardi V, Chai L, Silberstein LE. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells. Am J Hematol. 2009 May; 84(5):273-8. PMID: 19358301.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  56. Nardi V, Naveiras O, Azam M, Daley GQ. ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokines. Blood. 2009 Apr 16; 113(16):3813-20. PMID: 19171873; PMCID: PMC2670796.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  57. Nardi V, Raz T, Cao X, Wu CJ, Stone RM, Cortes J, Deininger MW, Church G, Zhu J, Daley GQ. Quantitative monitoring by polymerase colony assay of known mutations resistant to ABL kinase inhibitors. Oncogene. 2008 Jan 31; 27(6):775-82. PMID: 17684485.
    Citations: 6     Fields:    Translation:Humans
  58. Raz T, Nardi V, Azam M, Cortes J, Daley GQ. Farnesyl transferase inhibitor resistance probed by target mutagenesis. Blood. 2007 Sep 15; 110(6):2102-9. PMID: 17536018; PMCID: PMC1976354.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  59. Azam M, Nardi V, Shakespeare WC, Metcalf CA, Bohacek RS, Wang Y, Sundaramoorthi R, Sliz P, Veach DR, Bornmann WG, Clarkson B, Dalgarno DC, Sawyer TK, Daley GQ. Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance. Proc Natl Acad Sci U S A. 2006 Jun 13; 103(24):9244-9. PMID: 16754879; PMCID: PMC1482597.
    Citations: 23     Fields:    Translation:HumansCells
  60. Santini G, De Souza C, Aversa S, Patti C, Tedeschi L, Candela M, Olivieri A, Chisesi T, Rubagotti A, Centurioni R, Nardi V, Congiu M, Gennaro M, Truini M. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group. Braz J Med Biol Res. 2004 May; 37(5):719-28. PMID: 15107935.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  61. Nardi V, Azam M, Daley GQ. Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr Opin Hematol. 2004 Jan; 11(1):35-43. PMID: 14676625.
    Citations: 40     Fields:    Translation:HumansCells
  62. Azam M, Raz T, Nardi V, Opitz SL, Daley GQ. A screen to identify drug resistant variants to target-directed anti-cancer agents. Biol Proced Online. 2003; 5:204-210. PMID: 14615817.
    Citations: 9     
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Nardi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (324)
Explore
_
Co-Authors (158)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.